Lost goodwill isn’t irreparable harm without more specifics, court says

Alfasigma USA, Inc. v. Nivagen Pharmaceuticals, Inc., No. 17-cv-01974-MCE-GGH,
2018 WL 1567820 (E.D. Cal. Mar. 30, 2018)
The parties make “medical foods,” which are intended to be
used under a doctor’s supervision; subscriptions for their use are common
though not required. They are not eligible for reimbursement by Medicaid,
Medicare, or many private insurers. Alfasigma makes Foltx and Breckenridge makes
a generic version called Folbic.
The pharmaceutical industry allegedly maintains a database
in which generic foods can be linked to their name brand equivalent through an
honor system. If a generic company “represents to industry databases that its
generic medical food contains the same active ingredients in the same amounts
as a certain branded product, the databases will link the generic to the brand.”  Nivagen makes a generic that it represented
was equivalent to Foltx and Folbic, causing it to be linked. “But Nivagen also
characterized its product as a prescription drug that requires an ‘Rx’ on the
label, thereby entitling users to reimbursement.” Nivagen also allegedly caused
its product Niva-Fol to be shown as having a National Drug Code or National
Health Related Items Code number, which are for approved drugs and medical
devices only, but which would qualify Niva-Fol for federal reimbursement. This conduct
allegedly gave Nivagen a competitive advantage.
The court found that plaintiffs hadn’t shown irreparable harm . The
claimed damages were all financially-based: that Nivagen’s actions had or will cause customers to seek lower prices from plaintiffs and/or buy from Nivagen instead and that its conduct would cause a “loss of goodwill” with certain customers, lost
market share, and “other economic losses.” “To the extent courts may consider a
loss of goodwill to be intangible under certain circumstances, those
circumstances are not present here.” 
[When are they present?  Who
knows?]  The claimed lost goodwill was
the only potentially intangible harm, but was entirely speculative at this
point.
Plaintiffs also argued that their harm was irreparable
because Nivagen wouldn’t be able to satisfy a judgment against it. The court
found it unlikely that “Nivagen is taking customers and stealing market share
at a rapid pace, while also making little profit doing so.” But also, the cases
supporting finding irreparable harm involved defendants who were insolvent or
deliberately dissipating funds to avoid judgment; there was no indication that
Nivagen was either.
Finally, plaintiffs’ delay undercut claims of irreparable
harm. Breckenridge sent Nivagen a letter in June 2015 indicating it knew of the
database linkage and accusing Nivagen of false advertising and unfair business
practices. Plaintiffs still waited until September 2017 to file suit, and
waited until October to move for a preliminary injunction, only then
unsuccessfully seeking expedited discovery to support their request for an
injunction, “which provides at least a tacit admission that they do not have
sufficient evidence to support the Motion as it stands.”
Nor did the balance of equities tip in plaintiffs’ favor. “Plaintiffs
have failed to so much as allege that customers are in fact choosing Nivagen’s
product over their products, let alone that they are doing so at a rate that
puts Plaintiffs’ businesses at risk of greater damages than would be caused by
enjoining Nivagen—a much smaller entity—from advertising, promoting, or selling
its product, and requiring it to change its labeling, correct any false
statements already made, and recall any product already sold.”
Finally, though the public interest favored protecting
consumers from false advertising, it also favored competition.

from Blogger https://ift.tt/2q2Cc2p

Advertisements
This entry was posted in Uncategorized and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s